Expression of p68 in human colon cancer

Tumor Biology

Volumn 16, Issue 5, 1995, Pages 281-289

  Singh, C ^a   Haines, G K ^b   Talamonti, M S ^a   Radosevich, James A ^a  

^a Research Service   (United States)

^b Departments of Pathology Surgery and Cancer Center/VA Surgery and Cancer Center/VA ^*  (United States)

Author keywords

Colon cancer; Immunohistochemistry; Monoclonal antibodies; TJ4C4; Tumor markers

Indexed keywords

PROTEIN KINASE; PROTEIN KINASE PP68; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SIZE; CELL DIFFERENTIATION; COLON CANCER; CONTROLLED STUDY; DEVELOPMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0029134011     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217945     Document Type: Article

References (28)

1. Cancer Facts and Figures-1990. Atlanta, American Cancer Society, Inc, 1990.
2. Cohen AM, Shank B, Friedman MA: Colorectal cancer; in DeVita VT Jr, Heilman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 3. Philadelphia, Lippincott, 1989, pp 895-964.
3. Berry MJ, Knutson GS, Lasky SR, Munemitsu SM, Samuel CE: Mechanisms of interferon action: Purification and specificities of the doublestranded RNA-dependent protein kinase from untreated and interferontreated mouse fibroblasts. J Biol Chem 1986,260:11240-11247.
4. Reichel PA, Merrick WC, Siekierka J, Mathews MB: Regulation of a protein synthesis initiation factor by adenovirusassociated RNAI. Nature 1985;313:196-200.
5. Hovanessian AG: The doublestranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Biol Chem 1987;9:641-647.
6. Meurs E, Chong K, Galabru J, Shaun N, Thomas T, Kerr IM, Williams BRG, Hovanesesian A: Molecular cloning and characterization of the human doublestranded RNA-activated protein kinase induced by interferon. Cell 1990;62: 379-390.
7. Galabru J, Hovanessian A: Autophosphorylation of the protein kinase dependent on the doublestranded RNA. J Biol Chem 1987; 262:15538-15544.
8. Matts RL, Levin DH, Petryshyn R, Thomas NS, London IM: Translation control of protein synthesis in reticulocyte lysates by eIF-2 alpha kinases; in Bermek E (ed): Mechanisms of Protein Synthesis. Berlin, Springer, 1984, pp 144-158.
9. Berry MJ, Knutson GS, Lasky SR, Munemitus SM, Samuel CE: Mechanism of interferon action: Purification and substrate specificities of the doublestranded RNA-dependent protein kinase from untreated and interferontreated mouse fibroblasts. J Biol Chem 1986:260: 11240-11247.
10. Meurs E, Chong K, Galabru J, Thomas NSB, Kerr IM, Williams BRG, Hovanessian AG: Molecular cloning and characterization of the human doublestranded RNA-activated protein kinase induced by interferon. Cell 1990;62:379-390.
11. Chong KL, Feng L, Schappert K, Meurs E, Donahue TF, Friesen JD, Hovanessian AG, Williams BRG: Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBOJ 1992;11:1553-1562.
12. Koromilas AE, Roy S. Barber GN, Katze MG, Sonenberg N: Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 1992:257: 1685-1688.
13. Taylor JL, Samuel CE, Grossberg SE: Antiviral and antidifferentiative activities of interferon beta and gamma in relation to their induction of doublestranded RNA-dependent protein kinase activity in 3T3-L1 cells. J Biol Chem 1988;263:1336-1341.
14. Radosevich JA, Ghadge GD, Haines GK, Malhotra P, Thimmapaya B: Characterization of the mouse monoclonal antibody TJ4C4 directed at human p68 kinase. Tumor Biol 1994;15:225-262.
15. Radosevich JA, Haines GK, Ghadge G, Thimmapaya B: A cellular 68,000 MW protein as a differentiation marker in human lung cancer; in Bernal SD, Hesketh PJ (eds): Lung Cancer Differentiation. New York, Dekker, 1992, vol 58, pp 87-102.
16. Haines GK, Ghadge G, Thimmapaya B, Radosevich JA: Expression of the protein kinase p68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch [B] 1992;62:151-158.
17. Haines GK, Ghadgc G, Thimmapaya B, Combs SG, Leslie W, Radosevich JA: Immunohistochcmical detection of doublestranded RNA-dependent protein kinase (p68) with a novel monoclonal antibody TJ4C4: A case report of an AIDS-related Kaposi's sarcoma treated with alphainterferon. Tumor Biol 1993;13:324-329.
18. Haines GK, Ghadge GD, Becker S, Kies M, Pelzer H, Thimmapaya B, Radoscvich JA: Correlation of the expression of doublestranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch [B] 1993;63:289-295.
19. Haines GK, Becker S, Ghadge G, Kies M, Pelzer H, Radosevich JA: Expression of the doublestranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region: Prognostic implications. Arch Otolaryngol Head and Neck Surg 1993:119: 1142-1147.
20. Haines GK, Ghadge GD, Radosevich JA: Expression of the p58 protein kinase as recognized by the monoclonal antibody TJ4C4 during human fetal development. Tumor Biol 1993;14:95-104.
21. Hsu SM, Raine L, Fanger H: The use of avidinbiotinpcroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochcm 1981;29:577-581.
22. Woman S, Mastromarino A: Markers of colonic cell differentiation. J Natl Cancer Inst 1984;72:497-500.
23. Jessup JM, Gallick GE: The biology of colorectal carcinoma. Curr Probl Cancer 1982;16:263-328.
24. Buick R, Poliak M: Perspective on clonogcnic tumor cells, stem cells, and oncogenes. Cancer Res 1984;44: 4909-4918.
25. Levenson R, Houseman D: Commitment: How do cells make the decision to differentiate? Cell 1981;25: 5-6.
26. Brattain M, Levine A, Chakrabarty S, Yeoman L, Wilson J, Long B: Heterogeneity of human colon carcinoma. Cancer Metastases Rev 1984; 3:177-191.
27. Hansen RM: Systemic therapy in metastatic colorectal cancer. Arch Intern Med 1990;150:2265-2269.
28. Grem JL, Jordan E, Robson ME, Binder RA, Hamilton JM, Steinberg SM, Arbuck SG, Beveridge RA. Kales AN, Miller JA, Wiess RB. McAtee N, Chen A, Goldspiel B, Sover E: Allegra: Phase II study of fluorouracil, leucovorin, and interferon AFa-2a in metastatic colorectal carcinoma. J Clin Oncol 1993; 11:1737-1745.